Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review

Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an established role in the management of refractory and rela...

Full description

Saved in:
Bibliographic Details
Published in:J Immunol Res
Main Authors: Fedele, Roberta, Martino, Massimo, Recchia, Anna Grazia, Irrera, Giuseppe, Gentile, Massimo, Morabito, Fortunato
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2015
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695673/
https://ncbi.nlm.nih.gov/pubmed/26788526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/968212
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items